Published on 27 May 2024 on Zacks via Yahoo Finance
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern.
Shares of this Zacks Rank #3 (Hold) company have risen 6.6% year to date compared with the industry’s 3.4% growth. The S&P 500 Index has risen 11.6% in the same time frame.